Adjuvant Radiotherapy
8
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
25%
2 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Comparison of Mastectomy Expander Trial
Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
Mat Pilates in Women With Breast Cancer During Adjuvant Radiotherapy
Quantitative Evaluation of the Breast's Morphological Variations During Radiotherapy: MorphoBreast3D
Stereotactic Hypofractionated Accelerated Radiotherapy Post-Prostatectomy
Zinc-L-Carnosine Prevents Dysphagia in Breast Cancer Patients Undergoing Adjuvant Radiotherapy